{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T10:00:32Z","timestamp":1772013632711,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10067-020-05490-w","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T23:50:31Z","timestamp":1604188231000},"page":"2047-2055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Population-level interest in anti-rheumatic drugs in the COVID-19 era: insights from Google Trends"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6311-8634","authenticated-orcid":false,"given":"Sinan","family":"Karde\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8677-2180","authenticated-orcid":false,"given":"Ali Suat","family":"Kuzu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8790-9991","authenticated-orcid":false,"given":"Haig","family":"Pakhchanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0636-3235","authenticated-orcid":false,"given":"Rahul","family":"Raiker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8060-970X","authenticated-orcid":false,"given":"Mine","family":"Karag\u00fclle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,31]]},"reference":[{"key":"5490_CR1","unstructured":"World Health Organization announces COVID-19 outbreak a pandemic. https:\/\/www.euro.who.int\/en\/health-topics\/health-emergencies\/coronavirus-covid-19\/news\/news\/2020\/3\/who-announces-covid-19-outbreak-a-pandemic\/. Accessed 12 Sept 2020"},{"key":"5490_CR2","unstructured":"World Health Organization. https:\/\/covid19.who.int\/. Accessed 12 Sept 2020"},{"key":"5490_CR3","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1007\/s10067-020-05387-8","volume":"39","author":"AP Ladani","year":"2020","unstructured":"Ladani AP, Loganathan M, Danve A (2020) Managing rheumatic diseases during COVID-19. Clin Rheumatol 39:3245\u20133254. https:\/\/doi.org\/10.1007\/s10067-020-05387-8","journal-title":"Clin Rheumatol"},{"key":"5490_CR4","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00296-020-04676-4","volume":"40","author":"F Montero","year":"2020","unstructured":"Montero F, Mart\u00ednez-Barrio J, Serrano-Benavente B, Gonz\u00e1lez T, Rivera J, Molina Collada J, Castrej\u00f3n I, \u00c1lvaro-Gracia J (2020) Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes. Rheumatol Int 40:1593\u20131598. https:\/\/doi.org\/10.1007\/s00296-020-04676-4","journal-title":"Rheumatol Int"},{"key":"5490_CR5","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00296-020-04635-z","volume":"40","author":"I Coskun Benlidayi","year":"2020","unstructured":"Coskun Benlidayi I, Kurtaran B, Tirasci E, Guzel R (2020) Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review. Rheumatol Int 40:1707\u20131716. https:\/\/doi.org\/10.1007\/s00296-020-04635-z","journal-title":"Rheumatol Int"},{"key":"5490_CR6","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s00296-020-04645-x","volume":"40","author":"F Haslak","year":"2020","unstructured":"Haslak F, Yildiz M, Adrovic A, Sahin S, Koker O, Aliyeva A, Barut K, Kasapcopur O (2020) Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic. Rheumatol Int 40:1423\u20131431. https:\/\/doi.org\/10.1007\/s00296-020-04645-x","journal-title":"Rheumatol Int"},{"key":"5490_CR7","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00296-020-04629-x","volume":"40","author":"E Kastritis","year":"2020","unstructured":"Kastritis E, Kitas GD, Vassilopoulos D, Giannopoulos G, Dimopoulos MA, Sfikakis PP (2020) Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes. Rheumatol Int 40:1353\u20131360. https:\/\/doi.org\/10.1007\/s00296-020-04629-x","journal-title":"Rheumatol Int"},{"key":"5490_CR8","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00296-020-04626-0","volume":"40","author":"E Seyahi","year":"2020","unstructured":"Seyahi E, Poyraz BC, Sut N, Akdogan S, Hamuryudan V (2020) The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey. Rheumatol Int 40:1229\u20131238. https:\/\/doi.org\/10.1007\/s00296-020-04626-0","journal-title":"Rheumatol Int"},{"key":"5490_CR9","doi-asserted-by":"publisher","unstructured":"Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, Chatham W, Cohen S, Costenbader K, Gravallese EM, Kalil AC, Weinblatt ME, Winthrop K, Mudano AS, Turner A, Saag KG (2020) American College of rheumatology guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic: version 2. Arthritis Rheumatol 72. https:\/\/doi.org\/10.1002\/art.41437","DOI":"10.1002\/art.41437"},{"key":"5490_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/annrheumdis-2020-217877","volume":"79","author":"RB Landew\u00e9","year":"2020","unstructured":"Landew\u00e9 RB, Machado PM, Kroon F, Bijlsma HW, Burmester GR, Carmona L et al (2020) EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Ann Rheum Dis 79:851\u2013858. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217877","journal-title":"Ann Rheum Dis"},{"key":"5490_CR11","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00296-020-04694-2","volume":"40","author":"DP Misra","year":"2020","unstructured":"Misra DP, Gasparyan AY, Zimba O (2020) Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates. Rheumatol Int 40:1741\u20131751. https:\/\/doi.org\/10.1007\/s00296-020-04694-2","journal-title":"Rheumatol Int"},{"key":"5490_CR12","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s10067-020-05073-9","volume":"39","author":"DP Misra","year":"2020","unstructured":"Misra DP, Agarwal V, Gasparyan AY, Zimba O (2020) Rheumatologists\u2019 perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol 39:2055\u20132062. https:\/\/doi.org\/10.1007\/s10067-020-05073-9","journal-title":"Clin Rheumatol"},{"key":"5490_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/BOR.0000000000000731","volume":"32","author":"EV Schrezenmeier","year":"2020","unstructured":"Schrezenmeier EV, Burmester GR, Eckardt KU, D\u00f6rner T (2020) Role for antimalarials in the management of COVID-19. Curr Opin Rheumatol 32:449\u2013457. https:\/\/doi.org\/10.1097\/BOR.0000000000000731","journal-title":"Curr Opin Rheumatol"},{"key":"5490_CR14","doi-asserted-by":"publisher","unstructured":"Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC et al (2020) Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa478","DOI":"10.1093\/cid\/ciaa478"},{"key":"5490_CR15","unstructured":"National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. https:\/\/covid19treatmentguidelines.nih.gov\/. Accessed 12 Sept 2020"},{"key":"5490_CR16","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.1157","volume":"11","author":"G Eysenbach","year":"2009","unstructured":"Eysenbach G (2009) Infodemiology and infoveillance: framework for an emerging set of public health informatics methods to analyze search, communication and publication behavior on the Internet. J Med Internet Res 11:e11. https:\/\/doi.org\/10.2196\/jmir.1157","journal-title":"J Med Internet Res"},{"key":"5490_CR17","doi-asserted-by":"publisher","DOI":"10.2196\/13439","volume":"5","author":"A Mavragani","year":"2019","unstructured":"Mavragani A, Ochoa G (2019) Google Trends in infodemiology and infoveillance: methodology framework. JMIR Public Health Surveill 5:e13439. https:\/\/doi.org\/10.2196\/13439","journal-title":"JMIR Public Health Surveill"},{"key":"5490_CR18","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s10067-018-4345-2","volume":"38","author":"S Karde\u015f","year":"2019","unstructured":"Karde\u015f S (2019) Seasonal variation in the internet searches for gout: an ecological study. Clin Rheumatol 38:769\u2013775. https:\/\/doi.org\/10.1007\/s10067-018-4345-2","journal-title":"Clin Rheumatol"},{"key":"5490_CR19","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s10067-018-4364-z","volume":"38","author":"G Martinez-Arroyo","year":"2019","unstructured":"Martinez-Arroyo G, Ramos-Gomez S, Rojero-Gil EK, Rojas-Gongora JA, Barajas-Ochoa A, Bustamante-Montes LP, Ya\u00f1ez J, Ramos-Remus C (2019) Potential uses of an infodemiology approach for health-care services for rheumatology. Clin Rheumatol 38:869\u2013876. https:\/\/doi.org\/10.1007\/s10067-018-4364-z","journal-title":"Clin Rheumatol"},{"key":"5490_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00403-019-01921-0","volume":"311","author":"S Karde\u015f","year":"2019","unstructured":"Karde\u015f S (2019) Seasonal variation in the internet searches for psoriasis. Arch Dermatol Res 311:461\u2013467. https:\/\/doi.org\/10.1007\/s00403-019-01921-0","journal-title":"Arch Dermatol Res"},{"key":"5490_CR21","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/nature07634","volume":"457","author":"J Ginsberg","year":"2009","unstructured":"Ginsberg J, Mohebbi MH, Patel RS, Brammer L, Smolinski MS, Brilliant L (2009) Detecting influenza epidemics using search engine query data. Nature 457:1012\u20131014. https:\/\/doi.org\/10.1038\/nature07634","journal-title":"Nature"},{"key":"5490_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003256","volume":"9","author":"DR Olson","year":"2013","unstructured":"Olson DR, Konty KJ, Paladini M, Viboud C, Simonsen L (2013) Reassessing Google Flu Trends data for detection of seasonal and pandemic influenza: a comparative epidemiological study at three geographic scales. PLoS Comput Biol 9:e1003256. https:\/\/doi.org\/10.1371\/journal.pcbi.1003256","journal-title":"PLoS Comput Biol"},{"key":"5490_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005607","volume":"13","author":"S Yang","year":"2017","unstructured":"Yang S, Kou SC, Lu F, Brownstein JS, Brooke N, Santillana M (2017) Advances in using Internet searches to track dengue. PLoS Comput Biol 13:e1005607. https:\/\/doi.org\/10.1371\/journal.pcbi.1005607","journal-title":"PLoS Comput Biol"},{"key":"5490_CR24","doi-asserted-by":"publisher","first-page":"e0165085","DOI":"10.1371\/journal.pone.0165085","volume":"12","author":"Y Teng","year":"2017","unstructured":"Teng Y, Bi D, Xie G, Jin Y, Huang Y, Lin B, An X, Feng D, Tong Y (2017) Dynamic forecasting of Zika epidemics using Google trends. PLoS One 12:e0165085. https:\/\/doi.org\/10.1371\/journal.pone.0165085","journal-title":"PLoS One"},{"key":"5490_CR25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/UPJ.0000000000000179","volume":"7","author":"HP Bhambhvani","year":"2020","unstructured":"Bhambhvani HP, Tijerina JD, Parham MJ, Greenberg DR, Eisenberg ML (2020) Public interest in elective urologic procedures in the COVID-19 pandemic: a Google Trends analysis. Urol Pract 7:496\u2013501. https:\/\/doi.org\/10.1097\/UPJ.0000000000000179","journal-title":"Urol Pract"},{"key":"5490_CR26","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1016\/j.arth.2020.05.051","volume":"35","author":"TK Jella","year":"2020","unstructured":"Jella TK, Samuel LT, Acu\u00f1a AJ, Emara AK, Kamath AF (2020) Rapid decline in online search queries for hip and knee arthroplasties concurrent with the COVID-19 pandemic. J Arthroplast 35:2813\u20132819. https:\/\/doi.org\/10.1016\/j.arth.2020.05.051","journal-title":"J Arthroplast"},{"key":"5490_CR27","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1007\/s00266-020-01903-y","volume":"44","author":"AK Dhanda","year":"2020","unstructured":"Dhanda AK, Leverant E, Leshchuk K, Paskhover B (2020) A Google Trends analysis of facial plastic surgery interest during the COVID-19 pandemic. Aesthet Plast Surg 44:1378\u20131380. https:\/\/doi.org\/10.1007\/s00266-020-01903-y","journal-title":"Aesthet Plast Surg"},{"key":"5490_CR28","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.jaad.2020.05.147","volume":"83","author":"AK Guzman","year":"2020","unstructured":"Guzman AK, Barbieri JS (2020) Analysis of dermatology-related search engine trends during the COVID-19 pandemic: implications for patient demand for outpatient services and telehealth. J Am Acad Dermatol 83:963\u2013965. https:\/\/doi.org\/10.1016\/j.jaad.2020.05.147","journal-title":"J Am Acad Dermatol"},{"key":"5490_CR29","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1001\/jamainternmed.2020.1764","volume":"180","author":"M Liu","year":"2020","unstructured":"Liu M, Caputi TL, Dredze M, Kesselheim AS, Ayers JW (2020) Internet searches for unproven COVID-19 therapies in the United States. JAMA Intern Med 180:1116\u20131118. https:\/\/doi.org\/10.1001\/jamainternmed.2020.1764","journal-title":"JAMA Intern Med"},{"key":"5490_CR30","unstructured":"Google Trends. https:\/\/trends.google.com\/trends\/. Accessed 9 Sept 2020"},{"key":"5490_CR31","unstructured":"https:\/\/www.uptodate.com\/. Accessed 7 Sept 2020"},{"key":"5490_CR32","unstructured":"Carbone C. New trial to test if anti-inflammatory drug colchicine prevents COVID-19 complications. https:\/\/www.foxnews.com\/science\/at-home-study-to-test-if-common-drug-prevents-covid-19-complications\/. Accessed 13 Sept 2020"},{"key":"5490_CR33","unstructured":"Hein A. Gout medication eyed as possible coronavirus treatment by researchers. https:\/\/www.foxnews.com\/health\/gout-medication-eyed-possible-coronavirus-treatment-by-researchers\/. Accessed 13 Sept 2020"},{"key":"5490_CR34","unstructured":"Rivas K. Tocilizumab drug shows coronavirus treatment promise, doctor says. https:\/\/www.foxnews.com\/health\/tocilizumab-drug-shows-coronavirus-treatment-promise-doctor-says\/. Accessed 13 Sept 2020"},{"key":"5490_CR35","unstructured":"Mandavilli A. The coronavirus patients betrayed by their own immune systems. https:\/\/www.nytimes.com\/2020\/04\/01\/health\/coronavirus-cytokine-storm-immune-system.html\/. Accessed 13 Sept 2020"},{"key":"5490_CR36","unstructured":"Dominus S. The Covid drug wars that pitted doctor vs. doctor. https:\/\/www.nytimes.com\/2020\/08\/05\/magazine\/covid-drug-wars-doctors.html\/. Accessed 13 Sept 2020"},{"key":"5490_CR37","unstructured":"Boseley S. Recovery trial for Covid-19 treatments: what we know so far. https:\/\/www.theguardian.com\/world\/2020\/jun\/16\/recovery-trial-for-covid-19-treatments-what-we-know-so-far\/. Accessed 13 Sept 2020"},{"key":"5490_CR38","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s40264-020-00953-0","volume":"43","author":"N Moore","year":"2020","unstructured":"Moore N, Carleton B, Blin P, Bosco-Levy P, Droz C (2020) Does ibuprofen worsen COVID-19? Drug Saf 43:611\u2013614. https:\/\/doi.org\/10.1007\/s40264-020-00953-0","journal-title":"Drug Saf"},{"key":"5490_CR39","unstructured":"https:\/\/twitter.com\/WHO\/status\/1240409217997189128\/. Accessed 13 Sept 2020"},{"key":"5490_CR40","doi-asserted-by":"crossref","unstructured":"World Health Organization. The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19. https:\/\/www.who.int\/publications\/i\/item\/the-use-of-non-steroidal-anti-inflammatory-drugs-(nsaids)-in-patients-with-covid-19\/. Accessed 13 Sept 2020","DOI":"10.15557\/PiMR.2020.0022"},{"key":"5490_CR41","doi-asserted-by":"publisher","first-page":"e001041","DOI":"10.1136\/rmdopen-2019-001041","volume":"5","author":"V Furer","year":"2019","unstructured":"Furer V, Rondaan C, Heijstek M, van Assen S, Bijl M, Agmon-Levin N, Breedveld FC, D\u2019Amelio R, Dougados M, Kapetanovic MC, van Laar JM, Ladefoged de Thurah A, Landew\u00e9 R, Molto A, M\u00fcller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, Elkayam O (2019) Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. RMD Open 5:e001041. https:\/\/doi.org\/10.1136\/rmdopen-2019-001041","journal-title":"RMD Open"},{"key":"5490_CR42","unstructured":"Grady D. The pandemic\u2019s hidden victims: sick or dying, but not from the virus. https:\/\/www.nytimes.com\/2020\/04\/20\/health\/treatment-delays-coronavirus.html\/. Accessed 13 Sept 2020"},{"key":"5490_CR43","doi-asserted-by":"publisher","unstructured":"Akintayo RO, Bahiri R, El Miedany Y, Olaosebikan H, Kalla AA, Adebajo AO et al (2020) African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic. Clin Rheumatol. https:\/\/doi.org\/10.1007\/s10067-020-05355-2","DOI":"10.1007\/s10067-020-05355-2"},{"key":"5490_CR44","unstructured":"Statcounter. https:\/\/gs.statcounter.com\/search-engine-market-share\/. Accessed 13 Sept 2020"},{"key":"5490_CR45","unstructured":"FDA adds Boxed Warning for increased risk of death with gout medicine Uloric (febuxostat). https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-adds-boxed-warning-increased-risk-death-gout-medicine-uloric-febuxostat\/. Accessed 13 Sept 2020"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05490-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05490-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05490-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T01:32:16Z","timestamp":1620351136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05490-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,31]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["5490"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05490-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,31]]},"assertion":[{"value":"20 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"SK received congress travel, accommodation, and participation fee support (12th Anatolian Rheumatology Days) from Abbvie. The other authors have no conflict of interest in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"NA","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"NA","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"NA","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}